(Q40152165)

18 September 2017

1 reference

title

Response criteria in urologic malignancies (English)

1 reference

18 September 2017

Response Criteria in Urologic Malignancies (English)

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

4 October 2023

author name string

F. M. Torti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6346422

4 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6346422

4 October 2023

publication date

1 January 1983

1 reference

full work available at URL

18 September 2017

http://link.springer.com/content/pdf/10.1007/978-3-642-81994-0_4

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Recent Results in Cancer Research

4 October 2023

published in

1 reference

18 September 2017

85

1 reference

18 September 2017

50-57

1 reference

Systemic treatment of advanced prostatic cancer: development of a new system for defining response.

18 September 2017

3

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

The use of serial bone scans in assessing response of bone metastases to systemic treatment

4 October 2023

4

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction

4 October 2023

5

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase

4 October 2023

6

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

The response to therapy of skeletal metastases from mammary cancer. Assessment by scintigraphy

4 October 2023

7

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

An index for monitoring bone metastases from carcinoma of the prostate

4 October 2023

8

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Estimation of Prostatic Size by Suprapubic Ultrasonography

4 October 2023

9

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Prognostic usefulness of serum acid phosphatase levels in carcinoma of the prostate.

4 October 2023

11

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Metastases from testicular carcinoma. Study of 78 autopsied cases.

4 October 2023

12

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Urinary hydroxyproline excretion as a marker of osseous metastasis in carcinoma of the prostate

4 October 2023

13

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinoma

4 October 2023

14

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Diagnosis and Staging of Prostatic Cancer by Transrectal Ultrasonography. A Preliminary Study

4 October 2023

15

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Nuclear bone imaging in metastatic cancer of the prostate

4 October 2023

17

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Osteoblastic response to successful treatment of metastatic cancer of the prostate

4 October 2023

18

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Will prostatic acid phosphatase determination by radioimmunoassay increase the diagnosis of early prostatic cancer?

4 October 2023

19

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Transrectal ultrasonography in the evaluation of patients with prostatic carcinoma

4 October 2023

20

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Ultrasonic evaluation of the prostatic nodule

4 October 2023

21

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

The importance of the stable category for chemotherapy treated patients with advanced and relapsing prostate cancer

4 October 2023

23

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

99m Tc-labeled polyphosphate as a skeletal imaging agent

4 October 2023

24

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

The chemotherapy of prostatic adenocarcinoma

4 October 2023

25

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Combined chemotherapy and surgery in treatment of advanced germ-cell tumors

4 October 2023

27

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Development and application of new equipment for transrectal ultrasonography.

4 October 2023

28

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

The predictive value of prostatic acid phosphatase as a screening test for prostatic cancer

4 October 2023

29

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

A critical analysis of response criteria in patients with prostatic cancer treated with CIS-diamminedichloride platinum II

4 October 2023

30

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

Clinical significance of the human acid phosphatases: a review

4 October 2023

31

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81994-0_4

4 October 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6346422

4 October 2023

1 reference